Five things for pharma marketers to know: Wednesday, October 11, 2017

Five things for pharma marketers to know: Wednesday, October 11, 2017

Pfizer considers sale of its consumer healthcare business; Express Scripts moves into patient benefit management; China to speed up drug approvals

Five things for pharma marketers to know: Tuesday, October 10, 2017

Five things for pharma marketers to know: Tuesday, October 10, 2017

Patients complain about positive healthcare ads; some drugmakers skirt Open Payment rules; new law requires disclosure of drug price hikes in California

Astellas turns to 'corporate branding 2.0'

Astellas turns to 'corporate branding 2.0'

The communications team, led by Jeff Winton, is again researching Astellas' reputation for an updated picture on where the campaign has gotten them so far.

Five things for pharma marketers to know: Friday, October 6, 2017

Five things for pharma marketers to know: Friday, October 6, 2017

AbbVie to pay $140 million to AndroGel patient; Trump likely to roll back birth-control mandate; patients more likely to respond to expensive drugs

Five things for pharma marketers to know: Thursday, October 5, 2017

Five things for pharma marketers to know: Thursday, October 5, 2017

Cigna will no longer cover OxyContin; the AMA no longer supports price-fixing to lower drug prices; Gottlieb is not in favor of 'right-to-try' laws

How Walgreens overcomes 'consumer complacency' during flu-shot season

How Walgreens overcomes 'consumer complacency' during flu-shot season

In the 2015-16 flu season, more than 145 million doses were distributed by manufacturers, according to the Centers for Disease Control and Prevention, but only 41% of American adults received a vaccine.

Five things for pharma marketers to know: Wednesday, October 4, 2017

Five things for pharma marketers to know: Wednesday, October 4, 2017

The FDA approves Mylan's Copaxone generic; 3 out of every 1,000 Americans face $50,000 in drug costs; some ACA premiums may rise by 50%

How a cancer nonprofit is using Comic Con in bid for new donors

How a cancer nonprofit is using Comic Con in bid for new donors

DKMS worked with Marino on PR for the campaign and with Area 23 on its Comic Con booth.

Medical journal ad spend in H1 2017: All the data in one place

Medical journal ad spend in H1 2017: All the data in one place

The top three most advertised brands were GlaxoSmithKline's Breo Ellipta, Eli Lilly's Trulicity, and Boehringer Ingelheim's Jardiance.

Five things for pharma marketers to know: Tuesday, October 3, 2017

Five things for pharma marketers to know: Tuesday, October 3, 2017

The FDA wants to improve the generic drug approval process; Allergan CEO responds to criticism of patent deal; breast cancer death rate dropped 40%

The professional paths of 8 pharma execs

The professional paths of 8 pharma execs

The successes of these pharma execs show that there's no one path to professional bliss.

How HUBs will evolve in the ever-changing healthcare landscape

How HUBs will evolve in the ever-changing healthcare landscape

The need to simplify access to treatment while finding new ways to keep patients engaged in their health and adherent is an undeniably growing trend.

Five things for pharma marketers to know: Monday, October 2, 2017

Five things for pharma marketers to know: Monday, October 2, 2017

The FDA tells 75 opioid drugmakers to fund training efforts; epilepsy drug reduces seizure frequency; FDA approves Novo's fast-acting mealtime insulin

AbelsonTaylor's Jay Carter on the key to retaining top talent

AbelsonTaylor's Jay Carter on the key to retaining top talent

Now that Facebook, Apple, and Google have set their sights on healthcare, agencies find themselves under pressure from yet another flank.

Pharma marketing salaries reach new heights, up 12.7% in 2017

Pharma marketing salaries reach new heights, up 12.7% in 2017

Salaries are up — by a lot — and marketers are enthusiastic about their career prospects.

Read the September 2017 digital edition

Read the September 2017 digital edition

Read the September 2017 issue in its entirety, including how marketing can save clinical trials.

Five things for pharma marketers to know: Friday, September 29, 2017

Five things for pharma marketers to know: Friday, September 29, 2017

Merck to stop developing hep.-C drugs; FDA approves new Lilly breast-cancer drug; California bill would outlaw co-pay cards

Five things for pharma marketers to know: Thursday, September 28, 2017

Five things for pharma marketers to know: Thursday, September 28, 2017

Universities stock vending machines with women's health products; AbbVie pays to delay Amgen's Humira biosimilar; more states likely to introduce off-label bills

WPP pulls out of Eurobest, threatens to leave Cannes

WPP pulls out of Eurobest, threatens to leave Cannes

A leaked email chain shows that WPP intends to withdraw from Ascential's Eurobest awards in London and is in discussions with the organizer about Cannes Lions.

Bank: Publicis and WPP are takeover targets, and Accenture is a 'credible buyer'

Bank: Publicis and WPP are takeover targets, and Accenture is a 'credible buyer'

Accenture or CapGemini are more likely to acquire the global agency networks than a Google or Oracle, according to a leading French bank.

Infographic | How often are drugmakers sharing clinical-trial data?

Infographic | How often are drugmakers sharing clinical-trial data?

The answer: it depends on what phase the trial is in.

Five things for pharma marketers to know: Wednesday, September 27, 2017

Five things for pharma marketers to know: Wednesday, September 27, 2017

AbbVie adds context to CEO's comments on drug pricing; Pandora makes a play for pharma ad dollars; shortages expected of drugs manufactured in Puerto Rico

One-quarter of global marketers report digital ads next to extremist content

One-quarter of global marketers report digital ads next to extremist content

Some of the world's marketers have reported specific examples of where their digital advertising appeared alongside offensive and compromising content.

The ugly truth about advertising's gender bias, and how to change it

The ugly truth about advertising's gender bias, and how to change it

Execs from JWT, J&J, and DanoneWeave react to the results of a new JWT/Geena Davis Institute study.

Five things for pharma marketers to know: Tuesday, September 26, 2017

Five things for pharma marketers to know: Tuesday, September 26, 2017

Patient assistance nonprofit contacted in Aegerion probe; most heavily marketed drugs in Canada offer little therapeutic value; the FDA pans Duchenne drug

Drugmakers turn to social — not TV — to market drugs to women

Drugmakers turn to social — not TV — to market drugs to women

Still, most experts characterize this year's newly approved women's health drugs as modest improvements rather than groundbreaking advances in medicine.

How Pablo Graiver plans to solve the problem of clinical-trial recruitment

How Pablo Graiver plans to solve the problem of clinical-trial recruitment

The CEO and founder of Antidote talks about what inspired him to start the company, which recently received funding from Merck.

Top 25 women's health brands, based on U.S. sales in 2016

Top 25 women's health brands, based on U.S. sales in 2016

Amgen's Prolia tops the list, according to data compiled by EvaluatePharma.

Healthcare agencies re-evaluate tactics to retain talent

Healthcare agencies re-evaluate tactics to retain talent

The best marketers possess a mix of scientific know-how, digital dexterity, and unflappability. To keep them, agencies need to revise their thinking and tactics.

Five things for pharma marketers to know: Monday, September 25, 2017

Five things for pharma marketers to know: Monday, September 25, 2017

The FDA declines to approve an opioid and a treatment for rheumatoid arthritis; KKR closes WebMD buyout; 60% of teens have received the HPV vaccine

Oscar Health launches open enrollment campaign, as funding is slashed for ACA ads

Oscar Health launches open enrollment campaign, as funding is slashed for ACA ads

The health insurance startup launched a campaign this week that urges people to get covered.

Five things for pharma marketers to know: Friday, September 22, 2017

Five things for pharma marketers to know: Friday, September 22, 2017

Express Scripts' Miller says new models needed to pay for CAR-T; FDA warns about Intercept drug deaths; CVS puts limits on opioid scripts

New pharma CEOs to face payer, pricing challenges

New pharma CEOs to face payer, pricing challenges

They are tasked with addressing an increasingly tough payer environment and ongoing criticism of the industry's drug-pricing practices.

Wieden+Kennedy and The Atlantic win ADCOLOR's Ad of the Year for Typecast

Wieden+Kennedy and The Atlantic win ADCOLOR's Ad of the Year for Typecast

Blood Equality for GMHC by FCB Health was another honoree for Ad of the Year.

Five things for pharma marketers to know: Thursday, September 21, 2017

Five things for pharma marketers to know: Thursday, September 21, 2017

Nestle to refocus Galderma's skin health R&D; Amazon is reportedly in talks with PBMs; most Americans do not actively read science news

Co-pay cards unlock the key to patient engagement

Co-pay cards unlock the key to patient engagement

Beyond providing access, co-pay cards represent a starting point to more powerful patient engagement.

At ADCOLOR, Five Woke Women challenge perceptions of identity in the workplace

At ADCOLOR, Five Woke Women challenge perceptions of identity in the workplace

A "seat at the table" isn't enough, says Oath's Allison Allen, in wide-ranging discussion at annual diversity conference.

Online patient communities consider the platform: Facebook, or somewhere more private?

Online patient communities consider the platform: Facebook, or somewhere more private?

Facebook itself has more than six million health-related groups.

Five things for pharma marketers to know: Wednesday, September 20, 2017

Five things for pharma marketers to know: Wednesday, September 20, 2017

Pfizer sues J&J over Remicade contracts; drugmakers trim sales forces for rare-disease drugs; Roche's oncology business under siege from biosimilars

New Cologuard ad tries humor to make colon screening accessible

New Cologuard ad tries humor to make colon screening accessible

Exact Sciences has found success by marketing Cologuard in ads airing on networks like MSNBC, CNN, and Fox News.

Five things for pharma marketers to know: Tuesday, September 19, 2017

Five things for pharma marketers to know: Tuesday, September 19, 2017

Only three of the seven FDA-approved biosimilars are available for sale; Teva to sell off women's health portfolio; the FDA approves GSK's COPD combo

American Cancer Society: 'We are more than just a research organization'

American Cancer Society: 'We are more than just a research organization'

The new brand campaign, Attacking Cancer from Every Angle, showcases all the services the organization provides.

UDG Healthcare acquires MicroMass, for up to $75.8 million

UDG Healthcare acquires MicroMass, for up to $75.8 million

The company also this year has purchased Vynamic and Cambridge BioMarketing.

Five things for pharma marketers to know: Monday, September 18, 2017

Five things for pharma marketers to know: Monday, September 18, 2017

Insurers rarely require prior authorization for opioids; court of appeals voids J&J win in Advil ads suit; new California law to address drug pricing

Accessible website design for users with disabilities lags far behind demand

Accessible website design for users with disabilities lags far behind demand

Too few of the billions of sites online are usable for disabled people, says AudioEye's CEO.

Is your brand's voice, male, female, human or mineral?

Is your brand's voice, male, female, human or mineral?

The rise of voice technology platforms and the connected home has turned the discussion of a brand's voice from metaphorical to physical.

Five things for pharma marketers to know: Friday, September 15, 2017

Five things for pharma marketers to know: Friday, September 15, 2017

The FDA approves first cancer biosimilar; it also approves Bayer's new lymphoma drug; clinical-trial participation for gynecological cancer drops

Sheryl Sandberg: 'Facebook must bring people together to do good'

Sheryl Sandberg: 'Facebook must bring people together to do good'

Facebook chief operating officer Sheryl Sandberg has said that in turbulent times the social network must do more than simply connect people.

Five things for pharma marketers to know: Thursday, September 14, 2017

Five things for pharma marketers to know: Thursday, September 14, 2017

One-third of clinical trials are never publicly registered; ICER revises PCSK9 cost-effectiveness analysis; flu shot linked to miscarriages

Giant brings on new brand experience lead, as Armstrong departs

Giant brings on new brand experience lead, as Armstrong departs

Aaron Sklar, formerly of Welltok, replaces Christine Armstrong, who moved on to a Silicon Valley health startup.

Q&A: On being a working mom

Q&A: On being a working mom

Guidemark Health's Tina Fascetti offers Medela's Katie Busse advice on being a working mother in healthcare marketing.

Five things for pharma marketers to know: Wednesday, September 13, 2017

Five things for pharma marketers to know: Wednesday, September 13, 2017

FDA closes pediatric study loophole; little evidence outcomes-based contracts are working; PBMs lobby against transparency efforts

Fitbit CMO Tim Rosa: 'We know consumers don't want the internet on their wrists'

Fitbit CMO Tim Rosa: 'We know consumers don't want the internet on their wrists'

Rosa talks about the wearable technology company's health and fitness plans and other areas of expansion.

Watch: Psychiatry body kicks off first recruitment campaign with emotive film

Watch: Psychiatry body kicks off first recruitment campaign with emotive film

The Royal College of Psychiatrists kicked off a six-week student recruitment campaign with a national media push and an emotive film voiced by patient testimony.

Amarin names its first chief commercial officer

Amarin names its first chief commercial officer

The drugmaker tapped Mark Salyer, who previously managed Teva's respiratory business.

Five things for pharma marketers to know: Tuesday, September 12, 2017

Five things for pharma marketers to know: Tuesday, September 12, 2017

Alexion to cut 600 jobs; Sage Therapeutics' experimental seizure drug fails to meet expectations; Apple is interested in medical and health activity

Study says drug development costs much less than previously estimated

Study says drug development costs much less than previously estimated

New research suggests that the oft-cited $2.6 billion estimate for bringing a drug to market is significantly overstated.

Allergan recruits Deion Sanders to get men to use Botox

Allergan recruits Deion Sanders to get men to use Botox

The company is looking to expand the marketing of its blockbuster cosmetic drug.

Five things for pharma marketers to know: Monday, September 11, 2017

Five things for pharma marketers to know: Monday, September 11, 2017

Teva names new CEO; Allergan transfers Restasis patent to skirt competition; Google invests in oncology

Five things for pharma marketers to know: Friday, September 8, 2017

Five things for pharma marketers to know: Friday, September 8, 2017

Pfizer receives warning letter over EpiPen manufacturing; Opdivo kidney-cancer trial shows improved survival rates; cancer patients who discuss costs with physicians pay less

Former Burson director to lead Brussels business of U.K.'s Incisive Health

Former Burson director to lead Brussels business of U.K.'s Incisive Health

Incisive Health will next month welcome Francesca Scassellati Sforzolini as head of its Brussels office.

The FDA issues its second enforcement letter of 2017

The FDA issues its second enforcement letter of 2017

The OPDP has only issued two letters in 2017, compared to 11 last year.

Five things for pharma marketers to know: Thursday, September 7, 2017

Five things for pharma marketers to know: Thursday, September 7, 2017

The FDA halts IO-combo trial for Opdivo; Lilly slashes 3,500 jobs; new asthma drug could treat wide range of patients

Five things for pharma marketers to know: Wednesday, September 6, 2017

Five things for pharma marketers to know: Wednesday, September 6, 2017

The FDA warns drugmaker over opioid promotion; Watson may not be living up to the hype; Merck acquires immuno-oncology biotech

Novo Nordisk settles allegations its sales reps obscured Victoza's risks

Novo Nordisk settles allegations its sales reps obscured Victoza's risks

The federal government alleged that the drugmaker instructed its sales reps to convey messages to doctors that downplayed the drug's safety risks.

How Lauren Schulz is shaping Dr. Reddy's OTC brands

How Lauren Schulz is shaping Dr. Reddy's OTC brands

She is director of OTC brand marketing at Dr. Reddy's Laboratories.

Five things for pharma marketers to know: Tuesday, September 5, 2017

Five things for pharma marketers to know: Tuesday, September 5, 2017

Novartis CEO Joe Jimenez to step down; Sanofi ends R&D plans for Zika vaccine; oncologists still struggle to predict metastasis

Can marketing techniques save clinical trials?

Can marketing techniques save clinical trials?

No crucial area in pharma is more desperately in need of a fix — or more stubbornly resistant to change.

Five things for pharma marketers to know: Friday, September 1, 2017

Five things for pharma marketers to know: Friday, September 1, 2017

600 patients are eligible for CAR-T therapy; the FDA halts Keytruda combo study for multiple myeloma; the regulator delays decision on Herceptin biosimilar

Omnicom continues organic growth lead over rival ad networks

Omnicom continues organic growth lead over rival ad networks

By comparison, Omnicom's client roster includes less consumer goods companies compared to rivals WPP and Publicis Groupe.

Five things for pharma marketers to know: Thursday, August 31, 2017

Five things for pharma marketers to know: Thursday, August 31, 2017

Pfizer develops Minecraft version for kids with hemophilia; Lilly to resubmit baricitinib to the FDA; pricing expert says Novartis CAR-T value contract is 'progress'

Infographic | The leaders of the global hepatitis-C market

Infographic | The leaders of the global hepatitis-C market

Despite approvals of competing products from AbbVie, Merck, and Bristol-Myers Squibb, Gilead remains the market leader.

Novartis' CAR-T therapy, now approved, faces questions about price and side effects

Novartis' CAR-T therapy, now approved, faces questions about price and side effects

The Swiss drugmaker is the first to receive FDA approval to market a CAR-T therapy.

Media is where agencies are hurting

Media is where agencies are hurting

Why is revenue growth at some of the agency groups lagging forecasts for global ad expenditure?

Five things for pharma marketers to know: Wednesday, August 30, 2017

Five things for pharma marketers to know: Wednesday, August 30, 2017

Nonprofits receive FDA approval for Chagas drug; Gilead's buyout of Kite will put it back in pricing fray; most cancer patients don't receive fertility info

Why use health plan apps? To search for specialists and understand drug coverage

Why use health plan apps? To search for specialists and understand drug coverage

Consumers younger than the age of 45 were most likely to use an app developed by their health plan.

Five things for pharma marketers to know: Tuesday, August 29, 2017

Five things for pharma marketers to know: Tuesday, August 29, 2017

Drug ads make up to 38% of prime time commercials; Merck considers whether to pursue FDA approval for anacetrapib; BMS and Daiichi partner

Havas CFO: Health agencies did not perform 'very well' in H1 2017

Havas CFO: Health agencies did not perform 'very well' in H1 2017

The Havas Health & You agencies have reported some wins, however, including new business from Sanofi and Bristol-Myers Squibb.

Experts say pharma's move to Snapchat is in the making

Experts say pharma's move to Snapchat is in the making

Alone among the best-known social platforms, Snapchat has failed to generate much enthusiasm from pharma. Here's why — and here's why that may change.

Read the complete August 2017 digital edition

Read the complete August 2017 digital edition

Read the August 2017 issue in its entirety, including our recap of the MM&M Hall of Femme event.

Five things for pharma marketers to know: Monday, August 28, 2017

Five things for pharma marketers to know: Monday, August 28, 2017

Gilead to acquire Kite; the FDA issues fewest number of warning letters since 2008; the regulator approves BI's Humira biosimilar

Why Sanofi's dengue fever vaccine fell short of expectations

Why Sanofi's dengue fever vaccine fell short of expectations

Dengvaxia's post-launch plight reflects the difficulties of launching a vaccine. Is this a harbinger for future vaccine-marketing efforts?

Top 25 vaccine products in 2016, based on U.S. sales

Top 25 vaccine products in 2016, based on U.S. sales

Pfizer's Prevnar tops the list, according to data compiled by EvaluatePharma.

Allergan and SNL's Vanessa Bayer tackle birth control questions with humor

Allergan and SNL's Vanessa Bayer tackle birth control questions with humor

The pharma company's Know Your Birth Control campaign is running for six months.

Five things for pharma marketers to know: Friday, August 25, 2017

Five things for pharma marketers to know: Friday, August 25, 2017

Google surveys for depression; patients with diabetes that adhere to their regimen had fewer ER visits; Biogen, Samsung scores Humira biosimilar approval in EU

Truth Initiative asks whether Big Tobacco is exploiting veterans and the mentally ill

Truth Initiative asks whether Big Tobacco is exploiting veterans and the mentally ill

News-style segments for MTV's Video Music Awards expose how brands have marketed cigarettes to already vulnerable groups.

Five things for pharma marketers to know: Thursday, August 24, 2017

Five things for pharma marketers to know: Thursday, August 24, 2017

Amgen publishes study assessing cost-effectiveness of Repatha; Brilinta reduces death in patients with heart-attack history; Roche drug gets priority review

GSW hires former McCann exec as president of North America

GSW hires former McCann exec as president of North America

The agency appointed Sonja Foster-Storch, previously president of McCann Echo, to fill a role that has been vacant since 2016.

Analysts on WPP: 'expected bad, got worse'

Analysts on WPP: 'expected bad, got worse'

Business analysts have generally agreed that WPP's half-year earnings fell below expectations given recent market commentary, but have offered mixed guidance going forward.

Five things for pharma marketers to know: Wednesday, August 23, 2017

Five things for pharma marketers to know: Wednesday, August 23, 2017

Doctors fret about price of Novartis' experimental CAR-T therapy; study finds digital pillboxes don't improve adherence; India awards Pfizer vaccine patent

Horizon CEO Tim Walbert knows patients because he is one

Horizon CEO Tim Walbert knows patients because he is one

He was diagnosed years ago with a handful of autoimmune conditions, treating them with drugs like Abbvie's Humira, which he helped commercialize.

Five things for pharma marketers to know: Tuesday, August 22, 2017

Five things for pharma marketers to know: Tuesday, August 22, 2017

Novartis launches MS study with Apple's ResearchKit; the FDA considering limiting risk info in drug ads; J&J loses baby powder lawsuit

Outcome Health hires former BMS exec Nancy Phelan

Outcome Health hires former BMS exec Nancy Phelan

She is working on commercial partnerships for the point-of-care company.

Investors put their money on point of care

Investors put their money on point of care

Two recent cash infusions suggest investors are bullish on point-of-care advertising. Is the channel ready for its moment in the spotlight?

Diabetes drugs must prove their value to payers, analysts say

Diabetes drugs must prove their value to payers, analysts say

CVS Health's decision to remove Lilly's Jardiance for J&J's Invokana has analysts wondering if exclusive pricing contracts could shape the future of the GLP-1 class.

Five things for pharma marketers to know: Monday, August 21, 2017

Five things for pharma marketers to know: Monday, August 21, 2017

The FDA approves Ironwood's gout drug; GSW names new president; Samsung and Takeda to partner on biologic development

Always ad '#LikeAGirl' returns to fight girls' fear of failure

Always ad '#LikeAGirl' returns to fight girls' fear of failure

Procter & Gamble has revived the campaign with a new spot tackling the lack of confidence during puberty.

Pharma's $6 billion annual ad spend targeted by media publishers

Pharma's $6 billion annual ad spend targeted by media publishers

Condé Nast, Time Inc., and Vice Media have all recently launched health content businesses.

Sanofi adds WPP to creative roster in agency review

Sanofi adds WPP to creative roster in agency review

WPP was added to Sanofi's creative agency roster and GroupM's Mindshare is the drugmaker's new global media agency of record.

Five things for pharma marketers to know: Friday, August 18, 2017

Five things for pharma marketers to know: Friday, August 18, 2017

Lawmakers to investigate pricing of MS drugs; Mylan will pay $465 million to resolve EpiPen allegations; the FDA approves Pfizer's new cancer drug